Requirements for Induction of Vitamin D-Mediated Gene Regulation in Normal Human B Lymphocytes 1

Journal of Immunology

Volumn 157, Issue 7, 1996, Pages 2900-2908

  Morgan, John W ^a,b   Morgan, Deborah M ^a   Lasky, Stephen R ^a   Ford, Dwayne ^a   Kouttab, Nicola ^a   Maizel, Abby L ^a  

^a BROWN UNIVERSITY   (United States)

^b ROGER WILLIAMS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCITRIOL RECEPTOR; CD40 ANTIGEN; CYTOCHROME P450; INTERLEUKIN 2; INTERLEUKIN 4; NUCLEAR PROTEIN; RECOMBINANT PROTEIN; STEROID MONOOXYGENASE; VITAMIN D 24 HYDROXYLASE; VITAMIN D 24-HYDROXYLASE;

ARTICLE; B LYMPHOCYTE; BIOSYNTHESIS; CELL CULTURE; CELL CYCLE; CELL NUCLEUS; DRUG EFFECT; ENZYME INDUCTION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOLECULAR GENETICS; MONOCYTE; NUCLEOTIDE SEQUENCE; REGULATORY SEQUENCE; T LYMPHOCYTE; TONSIL; UPREGULATION;

ANTIGENS, CD40; B-LYMPHOCYTES; BASE SEQUENCE; CALCITRIOL; CELL CYCLE; CELL NUCLEUS; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INDUCTION; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-2; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; MONOCYTES; NUCLEAR PROTEINS; RECEPTORS, CALCITRIOL; RECOMBINANT PROTEINS; REGULATORY SEQUENCES, NUCLEIC ACID; STEROID HYDROXYLASES; T-LYMPHOCYTES; TONSIL; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0030266859     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Haussler, M. R., P. W. Jurutka, J. C. Hsieh, P. D. Thompson, S. H. Selznick, C. A. Haussler, and G. K. Whitfield. 1995. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone. Bone 17:33S.
2. 3 in vitro. Proc. Natl. Acad. Sci. USA 81:931.
3. Pryke, A. M., C. Duggan, C. P. White, S. Posen, and R. S. Mason. 1990. Tumor necrosis factor-alpha induces vitamin D-1-hydroxylase activity in normal human alveolar macrophages. J. Cell. Physiol. 142:652.
4. 3 production by cultured porcine alveolar macrophages. Mol. Cell. Endocrinol. 75:163.
5. Dusso, A. S., J. Finch, A. Brown, C. Ritter, J. Delmez, G. Schreiner, and E. Slatopolsky. 1991. Extrarenal production of calcitriol in normal and uremic humans. J. Clin. Endocrinol. Metab. 72:157.
6. 3 by hematopoietic cells. Prog. Clin. Biol. Res. 332:81.
7. 3 in human peripheral blood mononudear cells: presence in monocytes and induction in T-lymphocytes following activation. J. Clin. Endocrinol. Metab. 57:1308-1310.
8. 3 promotes in vitro morphological and enzymatic changes in normal human monocytes consistent with their differentiation into macrophages. Bone 7:23.
9. 3 receptors in human leukocytes. Science 221:1181.
10. 3: a novel immunoregulatory hormone. Science 224:1438.
11. Provvedini, D. M., C. D. Tsoukas, L. J. Deftos, and S. C. Manolagas. 1986. 1α,25-dihydroxyvitamin D3-binding macromolecules in human B lymhocytes: effects on immunoglobulin production. J. Immunol. 136:2734.
12. 3-mediated gene regulation in human B lymphocytes. J. Biol. Chem. 269:13437.
13. 3 (calcitrol). J. Clin. Invest. 74: 1451.
14. 3: specific inhibition at the level of messenger RNA. J. Clin. Invest. 79:1659.
15. Manolagas, S. C., D. M. Provvedini, E. J. Murray, C. D. Tsoukas, and L. J. Deftos. 1986. The antiproliferative effect of calcitriol on human peripheral blood mononuclear cells. J. Clin. Endocrinol. Metab. 63:394.
16. 3 regulates c-myc mRNA levels in tonsillar T lymphocytes. Immunology 74:589.
17. Alroy, I., T. L. Towers, and L. P. Freedman. 1995. Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol. Cell. Biol. 15:5789.
18. 3 on in vitro immunoglobulin production in human B cells. J. Immunol. 136:4427.
19. 3-mediated inhibition of B cell differentiation. Clin. Exp. Immunol. 69:639.
20. 3 inhibits proliferative response of T- and B-lymphocytes in a serum free culture. Int. J. Immunopharmacol. 9:719.
21. 3 suppresses human T helper/inducer lymphocyte activity in vitro. J. Immunol. 34:3032.
22. 3 mediated inhibition of B cell function in vitro. Immunopharmacology 21:121.
23. 3 receptor. Proc. Natl. Acad. Sci. USA 79:7719.
24. Clark, E. A., and J. A. Ledbetter. 1986. Activation of human B cells mediated through two distinct cell surface differentiation antigens. Proc. Natl. Acad. Sci. USA 83:4494.
25. Sundstrom, C., and K. Nillson. 1976. Establishment and characterization of a human histiocytic lymptioma cell line (U-937). Int. J. Cancer 17:565.
26. Mond, J. J., and M. Brunswick. 1995. Assays for B cell function. In Current Protocols in Immunology, Vol. 3. J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. John Wiley & Sons, Inc., New York, pp. 3.8.11-3.8.13.
27. Look, A. T., S. L. Melvin, and D. L. Williams. 1982. Aneuploidy and percentage of S-phase cells determined by flow cytometry correlate with cell phenotype in childhood acute leukemia. Blood 60:959.
28. Yaseen, N. R., A. L. Maizel, F. Wang, and S. Sharma. 1993. Comparative analysis of NFAT (nuclear factor of activated T cells) complex in human T and B lymphocytes. J. biol. Chem. 268:14285.
29. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248.
30. 24 gene. Nucleic Acids Res. 22:2410.
31. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
32. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Extraction, purification and analysis of messenger RNA from eukaryotic cells. In Molecular Cloning: A Laboratory Manual. Vol. 1. C. Nolan, ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 7.3-7.50.
33. Hahn, C. N., E. Baker, P. Laslo, B. K. May, J. L. Omdahl, and G. R. Sutherland. 1993. Localization of the human vitamin D 24-hydroxylase gene (CYP24) to chromosome 20113.2→q13.3. Cytogenet. Cell Genet. 62:192.
34. Gendelman, H. E., R. M. Friedman, S. Joe, L. M. Baca, J. Turpin, G. Dveksler, M. S. Meltzer, and C. Dieffenbach. 1990. A selective defect of interferon α production in human immunodeficiency virus-infected monocytes. J. Exp. Med. 172:1433.
35. 3 receptors in human monocyte-like cell line (U937) and a cloned human T lymphocyte. In Vitamin D: Chemical, Biochemical and Clinical Endocrinology of Calcium Metabolism. A. W. Norman, K. Schaefer, H.-G. Grigoleit, and D. von Herrath, eds. Walter de Gruyter & Co., Berlin, pp. 83-85.
36. Olsson, I., U. Gullberg, I. Ivhed, and K. Nilsson. 1984. Induction of differentiation of the human histiocytic lymphoma cell line U937 by 1α,25-dihydroxycholecalciferol. Cancer Res. 43:5862.
37. Kahlen, J. P., and C. Carlberg. 1994. Identification of a vitamin D receptor homodimer-type response element in the rat calcitriol 24-hydroxylase gene promoter. Biochem. Biophys. Res. Commun. 202:1366.
38. 3 24-hydroxylase gene. J. Biol. Chem. 269:10545.
39. 3) 24-hydrosylase gene. Biochemistry 91:900.
40. Kurokawa, R., V. Yu, A. Naar, S. Kyakumoto, Z. Han, S. Silverman, M. G. Rosenfeld, and C. K. Glass. 1993. Differential orientations of the DNA binding domain and C-terminal dimerization interface regulate binding site selection by nuclear receptor heterodimers. Genes Dev. 7:1423.
41. 3. Proc. Natl. Acad. Sci. USA 86:4455.
42. Ozono, K., J. Liao, S. A. Kerner, B. W. O'Malley, and J. W. Pike. 1990. The vitamin D-responsive element in the human osteocalcin gene. J. Biol. Chem. 265:21881.
43. 3 enhancement of mouse secreted phosphoprotein 1 (Spp-1 or osteopontin) gene expression. Proc. Natl. Acad. Sci. USA 87:9995.
44. Hewison, M., S. Barker, A. Brennan, J. Nathan, D. R. Katz, and J. L. H. O'Riordan. 1989. Autocrine regulation of 1,25-dihydroxycholecalciferol metabolism in myelomonocytic cells. Immunology 68:247.
45. Muraguchi, A., J. H. Kehrl, D. L. Longo, D. J. Volkman, K. A. Smith, and A. S. Fauci. 1985. Interleukin 2 receptors on human B cells: implications for the role of interleukin 2 in human B cell function. J. Exp. Med. 161:181.
46. Blanchard, D., C. Gaillard, P. Hermann, and J. Banchereau. 1994. Role of CD40 antigen and interleukin-2 in T cell-dependent human B lymphocyte growth. Eur. J. Immunol. 252:330.
47. Ledbetter, J. A., G. Shu, M. Gallagher, and E. A. Clark. 1987. Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen BP50 (CDW40). J. Immunol. 138:788.
48. Gordon, J., M. J. Millsum, L. Flores-Romo, and S. Gillis. 1989. Regulation of resting and cycling human B lymphocytes via surface IgM and the accessory molecules interleukin-4, CD23 and CD40. Immunology 68:526.
49. 3 receptor distribution and effects in subpopulations of normal human T lymphocytes. J. Clin. Endocrinol. Metab. 68:774.
50. Arbour, N. C., J. M. Prahl, and H. F. DeLuca. 1993. Stabilization of the vitamin D receptor in rat osteosarcoma cells through the action of 1,25-dihydroxyvitamin D3. Mol. Endocrinol. 7:1307.
51. 3 metabolism limits receptor occupancy and target tissue responsiveness. J. Biol. Chem. 264:15917.
52. Galibert, L., N. Burdin, B. de Saint-Vis, P. Garrone, C. Van Kooten, J. Banchereau, and F. Rousset. 1996. CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype. J. Exp. Med. 183:77.
53. Horst, R. L., E. T. Littledike, J. L. Riley, and J. L. Napoli. 1981. Quantitation of vitamin D and its metabolites and their plasma concentrations in five species of animals. Anal. Biochem. 116:189.
54. 3-modulated heterodimer. J. Biol. Chem. 266:23296.
55. 3 receptor (VDR) homodimers into VDR-retinoid X receptor heterodimers. Mo. Cell. Biol. 14:3329.
56. Walters, M. R. 1992. Newly identified actions of the vitamin D endocrine system. Endocr. Rev. 13:719.